SS-31 vs Thymosin Alpha-1
SS-31 and Thymosin Alpha-1 are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.
How they actually differ
Comparing the two: SS-31 is mitochondria-targeting aromatic-cationic tetrapeptide (cardiolipin-binding), while Thymosin Alpha-1 is n-acetylated 28-residue thymic peptide — different molecular classes with different handling consequences; their leading degradation routes differ (adsorptive loss to plasticware from the cationic charge for SS-31, deamidation and aspartate isomerisation in this asn/asp-rich sequence for Thymosin Alpha-1), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
SS-31 — origin
SS-31 (Elamipretide) is a Szeto-Schiller aromatic-cationic tetrapeptide (D-Arg-2',6'-dimethyltyrosine-Lys-Phe-NH2) that concentrates in the inner mitochondrial membrane and binds cardiolipin, the lipid unique to that membrane. Its structure is the reason it is studied specifically at the mitochondrion rather than as a general antioxidant.
Thymosin Alpha-1 — origin
Thymosin Alpha-1 is an N-terminally acetylated 28-amino-acid peptide derived from prothymosin alpha and originally isolated from thymic tissue. It is one of the most-studied immune-modulating peptides, examined for a role in T-cell maturation and immune signalling; the clinical formulation is known as Zadaxin.
SS-31 research themes
Studied for selective association with cardiolipin in the inner mitochondrial membrane, the basis of its mitochondrial targeting.
Examined for effects on mitochondrial energy production in research models of mitochondrial dysfunction.
Investigated around reactive-oxygen-species handling at the mitochondrion.
Thymosin Alpha-1 research themes
Studied for a role in the maturation and function of T-cells in immune research models.
Examined around innate immune signalling pathways, including Toll-like-receptor involvement, in preclinical work.
Investigated in models of immune response to infection and as a research adjuvant.
SS-31 handling
- Reach room temperature before opening.
- Use low-bind labware and buffers at low working concentrations to limit adsorption of the cationic peptide.
- Aliquot and refrigerate.
Thymosin Alpha-1 handling
- Reach room temperature before opening.
- Swirl to dissolve; the disordered peptide clears quickly.
- Label aliquots with reconstitution date and diluent.
Both third-party tested
Every Popular Peptides batch of SS-31 and Thymosin Alpha-1 is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
SS-31 reference
Related comparisons
SS-31 and Thymosin Alpha-1 are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.